You want straight answers about Kadian extended-release morphine therapy—what it is, when it’s considered, and how to use it safely. At Road To Recovery’s outpatient clinics across Ontario, we provide evidence-based, judgment-free care to help you stabilize and move forward. This complete guide explains how Kadian (slow-release oral morphine, or SROM) may fit within Opioid Agonist Therapy (OAT) for opioid use disorder, and how our team supports safer day-to-day routines.

Above the Fold: What You’ll Get + Table of Contents

• What you’ll learn:
  • Plain-language definition of Kadian extended-release morphine therapy (SROM)
  • When SROM may be considered within OAT in Canada
  • How Kadian compares with Methadone, Suboxone (buprenorphine/naloxone), and Sublocade
  • Daily safety practices, interaction cautions, and harm-reduction steps
  • How Road To Recovery streamlines same-day intake and psychiatry referrals
• Why it matters:
  • Some people don’t tolerate first-line OAT medicines; SROM can be an alternative under medical supervision
  • Steadier symptom control may support work, family, and health routines
  • Whole-person care (medication + mental health + resources) improves outcomes
• Who this is for:
  • Individuals and families evaluating medication-assisted treatment options
  • People seeking confidential, judgment-free addiction care with reduced wait times
  • Clinicians and helpers who want a concise, practical reference

• Summary
• What Is Kadian Extended-Release Morphine Therapy?
• Why Kadian Can Matter in Recovery
• How Kadian Works (Plain-Language Overview)
• Where Kadian Fits Among OAT Options
• Best Practices for Safe, Effective Use
• Tools and Resources That Make a Difference
• Case Examples (Ontario Clinics)
• FAQ
• Key Takeaways
• Conclusion + Next Steps

Summary

• Focus: Educational guide about Kadian extended-release morphine therapy in the context of OAT for opioid use disorder.
• Scope: What Kadian/SROM is, when it’s considered, safety tips, comparisons with Methadone/Suboxone/Sublocade, and support options.
• Outcome: Help you prepare informed questions and next steps with a clinician in a confidential, judgment-free setting.

What Is Kadian Extended-Release Morphine Therapy?

Kadian is an extended-release formulation of morphine sulfate designed to deliver medication over many hours. In addiction medicine in Canada, Kadian is often referred to as slow-release oral morphine (SROM) and may be considered by specialized clinicians as part of Opioid Agonist Therapy when other options—like Methadone or Buprenorphine-based treatments—are not suitable or were not effective. While morphine ER is also prescribed for chronic pain, our focus here is the OAT context, where structured monitoring and comprehensive supports are essential.

• Core concept: Extended-release pellets inside the capsule release morphine gradually to support steadier levels.
• OAT goal: Reduce withdrawal and cravings while supporting stability, harm reduction, and daily functioning.
• Jurisdiction note: SROM in OAT is used within Canadian clinical pathways; U.S. labeling emphasizes chronic pain. Always follow local clinical guidance.
• Whole-care mindset: Best outcomes pair medication with counseling, mental health support, family resources, and practical tools.

Why Kadian Can Matter in Recovery

People respond differently to medications. When first-line OAT options are not tolerated or don’t control symptoms, a carefully supervised transition to Kadian may improve comfort and adherence.

• Steadier days: The extended-release profile can smooth peaks and valleys for some patients.
• Potential tolerability: Individuals who struggle with side effects on other OAT medications may do better on SROM.
• Function-first: The aim is safer, more predictable days—so you can focus on work, school, and family.
• Supports matter: Counseling, peer support, and mental health services strengthen recovery.

How Kadian Works (Plain-Language Overview)

Morphine is an opioid agonist that binds to specific receptors in the brain and body. Kadian’s extended-release pellets are designed to deliver morphine over time, helping maintain steadier levels.

• Release curve: The capsule contains tiny pellets that should be swallowed whole. Do not crush, chew, or dissolve.
• Dosing rhythm: Often taken once daily in OAT, but your schedule is individualized by your clinician.
• Food considerations: In some programs, pellets may be sprinkled on a small amount of soft food and swallowed without chewing—only if your clinician confirms.
• Critical safety: Never inject, snort, or otherwise tamper with capsules or pellets; tampering can be fatal.

What You May Feel (and What to Watch)

• Expected effects: Reduced withdrawal, fewer cravings, and steadier mood for many patients.
• Common side effects: Nausea, constipation, drowsiness, sweating, and itchiness—report concerns early.
• Urgent red flags: Severe drowsiness, breathing problems, confusion, or unresponsiveness—seek immediate help.
• Interactions: Alcohol, benzodiazepines, and other sedatives increase overdose risk; share all meds and substances with your clinician.

Where Kadian Fits Among OAT Options

Different medications meet different needs. Here’s a concise comparison to review with your care team. For a deeper dive into the overall approach, see our Opioid Agonist Therapy overview.

Medication	What It Is	Typical Use	Pros	Considerations
Methadone	Full opioid agonist	First-line OAT in many programs	Strong withdrawal control; decades of outcomes data	Side effects for some; careful titration; ECG and monitoring may be required
Suboxone (buprenorphine/naloxone)	Partial agonist + antagonist	First-line OAT; often office-based	Lower overdose risk; fewer interactions; flexible care settings	Must time induction; can precipitate withdrawal if started too early
Sublocade (extended-release buprenorphine)	Monthly injection	Maintenance after buprenorphine stabilization	No daily dosing; privacy; steady levels	Requires initial stabilization; site reactions possible
Kadian / SROM (morphine ER)	Extended-release morphine	Considered in Canada when first-line OAT options aren’t a fit	Some patients report better tolerability and stability	Strict safety protocols; overdose risk if misused; close monitoring

Choosing a medication is personal and practical. Your history, side effects, life routines, and preferences matter. For context on choosing between first-line options, see our discussion of Suboxone vs. Methadone.

Best Practices for Safe, Effective Use

• Start with a full assessment:
  • Medical history, other medications, substance use patterns, and mental health review
  • Clear goals: stabilization, harm reduction, or steps toward transition
  • Family or support person involvement when helpful
• Follow the plan exactly:
  • Take Kadian only as prescribed—no self-adjusting doses
  • Keep scheduled check-ins; safety improves with regular monitoring
  • Report side effects early so your clinician can adjust
• Never tamper:
  • Do not crush, chew, split, inject, or inhale pellets—tampering can be life-threatening
  • Use only clinician-approved methods for swallowing pellets if needed
• Check interactions:
  • Avoid alcohol and sedatives unless explicitly reviewed with your clinician
  • Share all prescriptions, OTC medicines, and supplements
  • Ask about warnings for new medications from other providers
• Keep naloxone on hand:
  • Train a friend or family member how to use it
  • Store kits in places you frequent (home, work bag)
  • Replace kits before expiration
• Practice secure storage:
  • Lock medications away from children, pets, and visitors
  • Don’t store capsules in weekly organizers if there’s tampering risk at home
  • Return unused meds per clinic guidance
• Build daily habits:
  • Use phone alarms and routines (same time, same setting)
  • Pair dosing with consistent activities (breakfast, morning coffee)
  • Use a simple checklist to track doses and appointments
• Combine with supports:
  • Counseling and peer support groups
  • Mental health care and psychiatry referrals when appropriate
  • Family education and resources

Tools and Resources That Make a Difference

• Secure online intake: Start from home to reduce wait times and align appointments with your schedule.
• Psychiatry referrals: Coordinated locally or virtually (including CAMH and OTN partners when appropriate) to address co-occurring conditions.
• Education hub: Practical articles like our Medication-Assisted Treatment benefits guide and harm-reduction resources help you plan.
• Support for families: Step-by-step guidance to help loved ones contribute to safety and stability.
• Harm reduction options: Learn how safer-supply and overdose-prevention strategies fit your plan; see our Safer Opioid Supply overview.

Case Examples (Ontario Clinics)

Toronto (Yonge & Dundas): Transition after side effects

• Challenge: Patient experienced persistent side effects with a first-line OAT option and missed doses due to discomfort.
• Approach: Comprehensive reassessment, counseling, and a supervised transition plan to Kadian extended-release morphine therapy.
• Outcome focus: Improved adherence, steadier mood, return to work hours, and a reinforced safety plan (including naloxone).

Barrie (Downtown): Stabilizing with a once-daily rhythm

• Challenge: Variable shift work caused dosing inconsistency and breakthrough cravings.
• Approach: Considered SROM with close follow-ups and digital reminders to rebuild routine.
• Outcome focus: Fewer peaks and valleys, better sleep, and more predictable family time.

Brampton: Building a bridge to future goals

• Challenge: Patient hoped to transition to buprenorphine but could not tolerate induction at the time.
• Approach: Interim stabilization using Kadian while mapping a stepwise plan for eventual transition.
• Outcome focus: Reduced chaotic use, safer nights, and a clearer path to long-term recovery goals.

FAQ

• Is Kadian the same as Methadone?
  No. Kadian contains morphine; methadone is a different full agonist. Individual response varies based on history, tolerance, and side effects.
• Can I switch from Methadone or Suboxone to Kadian?
  Possibly, with physician oversight. Transitions require careful timing, monitoring, and safety planning tailored to you.
• Is Kadian used for chronic pain or opioid use disorder?
  Both exist in clinical practice, but pathways differ by country. In Canada, SROM can be considered in OAT; always follow local guidance.
• What if I miss a dose?
  Don’t double up. Contact your clinic for instructions—plans vary with your stability and program protocols.
• Can I drive while taking Kadian?
  Avoid driving until you know how it affects you and your clinician confirms it’s safe; sedation increases risk.

Key Takeaways

• Kadian extended-release morphine therapy (SROM) can support stability when first-line OAT options aren’t a fit.
• Safety first: Never tamper; disclose all medications; keep naloxone; attend follow-ups.
• Whole-person care: Medication works best with counseling, mental health support, and family resources.
• Next best step: Consider a same-day intake at Road To Recovery to review your history, goals, and options.

Conclusion + Next Steps

• Assess fit: If you’ve struggled with side effects or control on first-line OAT, discuss SROM with a clinician.
• Plan safety: Set up naloxone, secure storage, and daily reminders before you start.
• Engage supports: Use counseling, mental health care, and family resources to strengthen results.
• Act today: Our judgment-free clinics across Ontario can coordinate nurse + physician assessment on the same day for new OAT patients.

Educational purposes only. This guide isn’t medical advice. Always follow your clinician’s directions and local medical guidance.